2026 Poster Presentations
Preliminary List as of 6 October. Please check back for more.
AstraZeneca
From Hit to Degrader: Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1a Degradation in Hypoxia
Carterra, Inc.
High-Throughput SPR Screening and Kinetic Characterization Using Carterra Vega™ with AI Binding Prediction Comparison
Eurofins Discovery
Accelerating Tyrosine Kinase Inhibitor Drug Discovery with Selective Late-Stage Functionalization Strategies
Gero Pte. Ltd.
ProtoBind-Diff: Protein-Conditioned Discrete Diffusion for Structure-Free Ligand Generation and Scoring
K-MEDI hub
Exploration of the Biodistribution of Lipid Nanoparticles for Potential Therapeutic Delivery in the Inner Ear
K-MEDI hub
Small-Molecule Disruption of the LIN28A/let-7b Interaction Attenuates the Aggressive and Proinflammatory Phenotype of Rheumatoid Arthritis Fibroblast-Like Synoviocytes
K-MEDI hub
Turning Retrieval Errors into Training Signals: BERT for Finding Failure Evidence for Drug Discovery AI
Medical University of Gdansk
Interpretable Machine Learning for the Prediction of Phospholipid Affinity Based on IAM-HPLC Data
Newcastle University
Evaluation of Physics-Based Pose Prediction and the Role of Receptor Flexibility in a Community Antiviral Blind Challenge
Pelago Bioscience AB
Unlocking Challenging Targets with CETSA Across Drug Discovery
Shionogi & Co., Ltd.
Oral Absorption Prediction via Hybrid Modeling: Integrating Physicochemical Simulation and Machine Learning
SYNthesis med chem and Viva Biotech Group of Companies
Linkerology & ADME Optimisation of BETAC-1, a Novel BRD4 Bifunctional Degrader
Universitat de Girona_ESQ6750002E
SAFR: Enabling Fragment-Based Drug Discovery with a Synthetic Binding Pose Data Set
University of Miami
PROTAC Builder Ecosystem: An Integrated Computational Platform for Structure-Guided Degrader Design and Evaluation
University of the Western Cape
Chemical Strategies to Exploit the ClpC:ClpP Protein Degradation Machinery in Gram-Positive Bacteria
Vernalis
A Diversified Covalent-Fragment Collection for Drug Discovery. The Vernalis Covalent Fragment Library – From Design to Screening
Vipergen ApS
DELs in Cells: Direct Discovery of p53–MDM2 PPI Inhibitors
X-Chem, Inc.
DEL Data-Driven Discovery of Brachyury (TBXT) Ligand Toward Chordoma Therapeutics
XtalPi, Inc.
Agentic AI for Autonomous Discovery